Effect of 1,25(OH)2 Vitamin D3 on Circulating Insulin-Like Growth Factor-I and β2 Microglobulin in Patients with Osteoporosis

This publication has 17 references indexed in Scilit:

• 1α,25(OH)2Vitamin D3-Regulated Expression of the Eukaryotic Genome
  Nutrition Reviews, 2009
• Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1995
• Effects of Insulin-like Growth Factor (IGF) Binding Proteins (BPs)-3 and -6 on DNA Synthesis of Rat Osteoblasts: Further Evidence for a Role of Auto-/Paracrine IGF I but Not IGF II in Stimulating Osteoblast Growth
  Biochemical and Biophysical Research Communications, 1995
• Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not
  Journal of Bone and Mineral Research, 1995
• Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats
  Bone, 1995
• Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency
  Bone and Mineral, 1993
• Insulin-like growth factor I stimulates bone turnover in osteoporosis
  The Lancet, 1992
• Dexamethasone and 1,25(OH)2 vitamin D3 modulate the synthesis of insulin-like growth factor-I in osteoblast-like cells
  Calcified Tissue International, 1991
• The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs?
  Journal of Endocrinology, 1990
• IGF-I Production by Mouse Osteoblasts
  Journal of Bone and Mineral Research, 1990